Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Luminescence : the Journal of Biological and Chemical Luminescence|November 12, 2019
Recent chemo-/biosensor and bioimaging studies based on indole-decorated BODIPYsEmrah Ozcan, Hasan Huseyin Kazan, Bunyemin Çoşut
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|August 3, 2017
Iron metabolism and drug resistance in cancerHasan Huseyin Kazan, Cagri Urfali-Mamatoglu, Ufuk Gunduz
Journal of Chemotherapy (Florence, Italy)|April 26, 2024
Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor originsGizem Damla Yalcin, Pelin Mutlu, Hasan Huseyin Kazan, et al.
Transboundary and Emerging Diseases|April 30, 2025
<i>In Silico</i> Assessment for Risk of Possible Human Transmission of FCoV-23Ahmet Caglar Ozketen, Hasan Huseyin Kazan, Cenk Serhan Özverel, et al.
American Journal of Medical Genetics. Part A|March 7, 2022
A de novo heterozygous HOXA11 variant in a patient with mesomelic dysplasia with urogenital abnormalitiesAbdullah Sezer, Ferda Emriye Perçin, Hasan Huseyin Kazan, et al.
The Journal of Obstetrics and Gynaecology Research|March 7, 2024
The interrelation between the high expression level of MIR34a and the trisomic abortion materialsElvin Kazancioglu, Esra Tug, Mehmet Ali Ergun, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
Design, Development, and Clinical Validation of a Novel Kit for Cell-Free DNA ExtractionEkin Çelik, Hande Güner, Gizem Kayalı, et al.
Congenital Anomalies|August 23, 2025
Chromosomal Microarray in Prenatal Diagnosis: A Single Center Experience From TürkiyeGulsum Kayhan, Meral Yirmibeş Karaoguz, Pınar Calis, et al.
Gene|December 5, 2024
Copy number variations of stepwise-selected doxorubicin-resistant MCF-7 cell linesHasan Huseyin Kazan, İrem Sinem Acınan, Başak Kandemir, et al.
Journal of Cellular Physiology|October 31, 2019
15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicinHasan Huseyin Kazan, Cagri Urfali-Mamatoglu, Gizem Damla Yalcin, et al.
Pageof 2